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Abstract
Background: Recent guidelines stressed the need to adopt different values of waist circumference (WC)
measurements to define abdominal obesity in different ethnic groups. The aim of this study is to identify WC
cutoff points in normotensive and hypertensive subjects which are diagnostic of abdominal obesity in a Middle
Eastern population and the prevalence of abdominal obesity in a nationwide sample.
Methods: Data were collected during phase-2 of the Egyptians National Hypertension Project survey. Blood
pressure, anthropometric measurements and laboratory studies were performed according to a standardized
protocol by trained personnel. To derive the cutoff points for WC, we applied the factor analysis on CV risk factors:
diabetes mellitus, decrease in HDL-C and increase in LDL-C, triglycerides and left ventricular mass index by
echocardiography.
Results: The sample included 2313 individuals above the age of 25 years. WC values (mean ± SD) were 88 ± 14
cm and 95 ± 14 cm for normotensive (NT) and hypertensive (HT) men respectively, and 89.6 ± 14.7 cm and 95.7 ±
15.9 cm for NT and HT women respectively. Applying factor analysis, the weighted average cutoff points were 93.5
cm for both NT and HT men and 91.5 and 92.5 cm for NT and HT women respectively. Based on these thresholds,
the prevalence of abdominal obesity was 48% in men and 51.5% in women.
Conclusion: This is the first report of specific abdominal obesity cutoff points in a Middle Eastern country. The
cutoff points were different from the Europid standards. There is a high prevalence rate of abdominal obesity
among Egyptians which is associated with increased prevalence of cardiometabolic risk factors.
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Background
Abdominal obesity has recently been considered an
established cardiometabolic risk factor (1,2). Individuals
with abdominal obesity are at a great risk of developing
diabetes and atherosclerotic cardiovascular disease
(CVD) (1-4). It comes next to elevated plasma lipids as
a population-attributable risk factor for acute myocardial
infarction (5). Abdominal obesity was considered by the
IDF as a prerequisite for the diagnosis of the metabolic
syndrome (3).
The diagnosis of abdominal obesity in routine clinical
practice depends on the measurement of waist circum-
ference (WC). In Egypt as well as other Arab and
Middle Eastern countries, the thresholds of WC diag-
nostic of abdominal obesity are arbitrary and were
derived from European data. Gender-specific cutoff
points were originally developed from a regression curve
that identified the WC values associated with body mass
index (BMI) ≥ 30 kg/m
2 in a large heterogenous sample
of white men and women(1) and are not based on asso-
ciation with CVD risk factors. WHO and IDF recom-
mended that the WC cutoff points used to define
central (abdominal) obesity should be different among
different ethnic groups(3,6) and that the Europid stan-
dards should be used in our Eastern Mediterranean
region until national data become available. Identifica-
tion of the normal cutoff values for each population is
needed for health policy planners when developing CVD
prevention programs, since universal criteria do not
apply on all races.
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from the Egyptian National Hypertension Project (NHP)
survey to identify the cutoff points of WC diagnostic of
abdominal obesity in Egyptian men and women and to
examine the prevalence of abdominal obesity and its
related cardiometabolic risk factors (RFs) among Egyp-
tians. We used the principal component factor analysis
(7,8) - which incorporates multiple RFs into a single
variable - to derive appropriate WC cutoff points.
Methods
Study population
Data of WC in Egyptians were collected during phase-2
of the Egyptian NHP survey. The survey was conducted
in 21 sampling locations in six Egyptian governorates,
representing all Egypt’s geographic areas and socioeco-
nomic groups. The details of sample design, field opera-
tions, and technique for blood pressure measurements,
laboratory tests and echocardiographic examination
were reported in previous publications (9-11).
The sample could not be considered representative of
the Egyptian population as in the second phase of the
survey, the hypertensive individuals were over-sampled.
Data of normotensives (NT) and hypertensives (HT)
were analyzed separately.
WC measurements were taken using an anthropo-
metric centimeter-measuring tape. WC was measured
from the horizontal plane midway between the lowest
lateral border of the rib cage and iliac crest.
Data about the socioeconomic status (SES) and urban/
rural residence were derived from the questionnaire in
phase 1 of the survey. Participants were classified into
three groups based on the SES: high, mid and low (8).
All participants gave their consent to participate in the
survey. The protocol was approved by the Institution
Review Board.
Definition of Risk Factors
We used the following criteria for defining the RFs: ele-
vated LDL-cholesterol; ≥130 mg/dL, low HDL-choles-
terol; < 50 mg/dL in women and 40 mg/dL in men,
increased triglycerides (TG); ≥ 150 mg/dL. Diabetes
mellitus was defined as fasting blood glucose ≥ 126 mg/
dL and/or post-prandial blood glucose ≥ 200 mg/dL.
Left ventricular hypertrophy (LVH) was diagnosed if left
ventricular mass index (LVMI) was > 125 gm/m
2 in
men and > 110 gm/m
2 in women (12).
Statistical Analysis
The statistical analysis was done using SPSS version 16.
Continuous variables were expressed as gender-specific
means and standard deviations while discrete variables
were expressed as gender-specific proportions. All statis-
tics were done for NT normotensive and HT
hypertensive men and women separately. WC was
divided into 6 categories (< 75, 75-, 85-, 95-, 105 and >
114.9 cm). The RFs data was tested against normality
assumption. Tests showed that the data was not nor-
mally distributed. So, non-parametric tests were used to
test the differences among different categories. We com-
pared the differences in RFs within different WC cate-
gories using Kruskal-Wallis test for the numerical
variables and Chi square test for the categorical vari-
ables. Differences were considered statistically significant
at p < 0.05.
The principal component factor analysis (7, 8) was
used in this study to identify the cutoff points diagnostic
of abdominal obesity. WC cutoff points were based on
the association with cardiometabolic RFs. Five risk fac-
tors were used: low HDL-C, high LDL-C, high TG, dia-
betes and LVH. The five RFs were used in a factor
analysis model to obtain a factor (first factor) that
accounts for most of the variability in the data, and was
used to determine the cutoff point of the WC through
the logistic regression technique.
The obtained factor was used as the outcome variable
with 2 categories (< median and ≥ median), and the WC
as the independent variable. Logistic regression predicted
probabilities were used to construct the Receiver Operat-
ing Characteristic (ROC) curves for men and women
separately. ROC curves were also estimated for NT and
HT individuals separately to avoid the effect of oversam-
pling HT individuals. The development of ROC curves
allowed the identification of the optimal cutoff point
which was considered in this study to be the point that
maximizes both specificity and sensitivity. This occurs
when specificity and sensitivity become almost equal.
Results
Baseline characteristics of the study subjects
The basic characteristics of the study subjects and the
prevalence of risk factors are shown in table (1). The
sample included 2313 individuals, 981 men and 1332
women. There was 754 NT) and 1559 (HT) individuals.
Data of WC were available for 964 men and equal num-
ber of women. The age ranged between 25 and 90 years.
The majority lived in urban areas (73.3%), while 26.7%
lived in rural areas.
WC Measurements
For NT and HT men, the mean WC values were 88 ±
14 and 95 ± 14 cm respectively while for NT and HT
women, they were 89.6 ± 14.7 and 95.7 ± 15.9 cm
respectively. (Table 1)
Risk factors according to WC category
Prevalence of RFs in different WC categories is shown
in table 2. Increased WC was associated with a higher
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men and HT women. The levels of plasma lipids, glu-
cose and LVMI were linearly related to WC measure-
ments in both NT and HT men and women (table 3)
except for HDL in NT women and LVMI in HT men
and women.
WC Cutoff Points for Abdominal Obesity
WC cutoff points were determined based on the asso-
ciation with RFs. Applying the score of the factor analy-
sis and determining the cutoff points using the ROC
curves, the cutoff points were 93.5 cm for NT and HT
men, while they were 91.5 cm for NT women and 92.5
cm for HT women. The area under ROC curve was 0.78
and 0.67 in NT and HT men respectively, while it was
0.7 and 0.63 in NT and HT women respectively (Figures
1, 2, 3, 4).
Prevalence of Abdominal Obesity
Using the present WC cutoff points determined by the
factor analysis approach, the prevalence of obesity in the
study population was 50%. There was no difference in
prevalence between men and women (48% and 51.5%
respectively). The prevalence of abdominal obesity in
NT men, HT men, NT women and HT women were
33.8%, 54.6%, 42.8% and 55.9% respectively. Figure (5
and 6) shows the prevalence of abdominal obesity in dif-
ferent age decades in NT and HT subjects. Above the
age of 45 years, the prevalence of abdominal obesity was
Table 1 Basic characteristics of the study subjects
NT men (n = 311) HT men (n = 670) NT women (n = 443) HT women (n = 889)
Age (years)
a 46.5 ± 13.7 55.1 ± 13.1 42 ± 11.4 53.9 ± 11.6
WC (cm)
a 88 ± 14.2 95 ± 14.4 89.6 ± 14.7 95.7 ± 15.9
BMI (kg/m
2)
a 25.9 ± 5 28.4 ± 6.1 29.2 ± 6.7 31.7 ± 7.5
SES (%)
Low 41.8 36.4 45.8 44.8
Mid 49.5 52.3 46 46.2
High 8.7 11.3 8.1 9
Geographic region (%)
Urban 71.1 73.6 70.4 73.1
Rural 28.9 26.4 29.6 26.9
Risk factors (%)
DM 7.7 26.9 8.5 24.2
LVH 5.9 19.2 3.1 16.2
Decreased HDL-cholesterol 51.2 52.1 70.6 69.8
Elevated LDL-cholesterol 28.5 36.1 35.8 47.3
Elevated TG 29.3 46.1 24.8 39
a The values are represented as means ± SD
Metabolic risk factors were defined according to the IDF criteria (9). Elevated TG ≥ 150 mg/dL; reduced HDL-cholesterol < 40 mg/dL for men and < 50 mg/dL for
women; elevated LDL-cholesterol ≥ 130 mg/dL; DM when fasting blood glucose ≥ 126 mg/dL or postprandial blood glucose ≥ 200 mg/dL; LVH when LVMI > 125
gm/m
2 in men and > 110 gm/m
2 in women.
Table 2 Prevalence of risk factors (%) in different WC
categories among NT and HT men and women
Risk Factors WC category (cm)
< 75 75- 85- 95- 105- > 114.9
NT men
DM 2.1 2.5 6.8 7.5 23.1 41.7
LVH 4.3 9.0 6.6 3.8 0 0
High TG 4.3 17.3 34.2 48.1 42.3 75.0
Low HDL 44.7 45.7 50.0 58.5 61.5 58.3
High LDL 17.0 21.0 29.6 46.2 19.2 50.0
HT men
DM 6.9 11.9 14.0 20.7 21.8 34.7
LVH 30.6 24.3 15.8 15.0 21.0 24.3
High TG 12.1 24.7 48.0 52.3 62.7 63.3
Low HDL 34.5 42.9 52.6 56.9 58.2 51.0
High LDL 22.4 27.4 35.1 36.7 43.9 49.0
NT women
DM 4.4 4.3 8.9 12.0 8.8 20.0
LVH 2.9 1.1 0.9 3.4 6.3 18.2
High TG 8.8 16.1 25.9 29.3 47.1 52.0
Low HDL 66.2 67.7 70.5 71.7 85.3 72.0
High LDL 22.1 31.2 34.2 40.4 52.9 45.8
HT women
DM 16.0 16.0 17.9 27.2 32.6 32.7
LVH 20.8 19.2 11.1 16.0 15.0 21.3
High TG 9.3 27.5 37.3 46.0 47.2 50.5
Low HDL 54.7 63.4 71.1 70.3 75.0 77.8
High LDL 40.5 38.5 38.7 56.0 49.7 58.6
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highest prevalence rate around middle age.
The prevalence rates of abdominal obesity differed
according to the SES and urban/rural residence. Table 4
shows the prevalence of abdominal obesity in different
SES groups and in urban/rural areas. Abdominal obesity
was more prevalent in urban than rural areas and in
middle and high SES compared to low SES.
Discussion
The diagnosis of abdominal obesity is based on measure-
ment of WC, exceeding a certain threshold establishes the
diagnosis. The available cutoff points were derived from
the white populations. These cutoff points may not be
applicable for other countries because of variations in
body proportions and body fat distribution in different
ethnic groups. Reported WC thresholds for abdominal
obesity were population and gender- specific (6). The IDF
recommended that the cutoff point used for the WC to
define abdominal obesity should be different among differ-
ent ethnic groups (3,6). The IDF and WHO recommend
the use of the European cutoff points (94 cm for men and
80 cm for women) in Egypt and other Eastern Mediterra-
nean countries until more specific data are available (3,6).
In the present study, we tried to report specific WC
cutoff points associated with increased cardiometabolic
risk among a Middle Eastern population. We used these
cutoff points to provide information about the preva-
l e n c eo fa b d o m i n a lo b e s i t yi nas a m p l eo fE g y p t i a n s
representative of all socioeconomic strata and geo-
graphic regions and including both NT and HT men
and women.
Table 3 Linear trends in plasma lipid and glucose levels (mg/dl) and LVMI (gm/m
2) in relation to different WC groups
among NT and HT men and women
Risk Factors WC category (cm) Linearity
< 75 75- 85- 95- 105- > 114.9 p
NT men
HDL 42 ± 10 41 ± 9 41 ± 10 38 ± 9 37 ± 7 40 ± 14 0.013
LDL 107 ± 24 105 ± 32 115 ± 32 128 ± 35 111 ± 27 152 ± 73 < 0.001
TG 106 ± 30 110 ± 41 154 ± 92 155 ± 66 172 ± 86 200 ± 71 < 0.001
FBS 86 ± 13 88 ± 16 92 ± 25 97 ± 42 112 ± 54 119 ± 35 < 0.001
PP 104 ± 28 111 ± 42 120 ± 46 117 ± 63 140 ± 72 140 ± 47 0.003
LVMI 89.7 ± 21 89.4 ± 25 89.3 ± 23 87.5 ± 21 89.4 ± 16 93.9 ± 16 0.997
HT men
HDL 44 ± 9 42 ± 10 40 ± 10 39 ± 10 39 ± 10 40 ± 11 0.021
LDL 108 ± 39 110 ± 33 118 ± 37 123 ± 42 129 ± 43 124 ± 35 0.003
TG 102 ± 38 132 ± 62 164 ± 88 177 ± 104 181 ± 84 194 ± 103 < 0.001
FBS 90 ± 16 108 ± 71 102 ± 42 105 ± 48 112 ± 52 123 ± 68 0.018
PPBs 111 ± 32 128 ± 64 135 ± 70 145 ± 73 146 ± 73 167 ± 69 0.005
LVMI 109.3 ± 35 101.6 ± 33 100.4 ± 29 99.95 ± 29 102.8 ± 32 114.2 ± 54 0.727
NT women
HDL 45 ± 11 44 ± 10 44 ± 11 44 ± 10 40 ± 9 45 ± 11 0.152
LDL 108 ± 28 115 ± 43 119 ± 37 120 ± 35 134 ± 38 123 ± 36 0.002
TG 99 ± 40 114 ± 48 124 ± 57 148 ± 98 142 ± 64 173 ± 90 < 0.001
FBS 95 ± 47 93 ± 22 96 ± 39 104 ± 98 97 ± 34 114 ± 52 0.032
PPBs 116 ± 51 118 ± 42 116 ± 41 131 ± 61 113 ± 34 147 ± 89 0.043
LVMI 73.7 ± 16 76.3 ± 18 75.7 ± 16 77.8 ± 16 85.1 ± 17 90.4 ± 25 < 0.001
HT women
HDL 48 ± 12 46 ± 11 45 ± 10 44 ± 10 43 ± 10 42 ± 11 < 0.001
LDL 120 ± 38 122 ± 36 123 ± 39 139 ± 45 137 ± 45 148 ± 50 < 0.001
TG 106 ± 44 137 ± 71 148 ± 67 161 ± 81 160 ± 75 168 ± 76 < 0.001
FBS 96 ± 21 102 ± 31 106 ± 46 122 ± 69 123 ± 63 127 ± 63 < 0.001
PPBs 135 ± 53 131 ± 47 147 ± 72 159 ± 88 159 ± 79 167 ± 82 < 0.001
LVMI 94.5 ± 38 92.6 ± 32 89.4 ± 24 93.3 ± 25 92.4 ± 25 95.2 ± 22 0.638
HDL: High density lipoprotein cholesterol
LDL: Low density lipoprotein cholesterol
TC: Total cholesterol
FBs: fasting blood sugar
PPBs: post prandial blood sugar.
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analysis approach. This approach was used by Razak et
al (8) to define obesity cutoff points in multiethnic
population, where ethnic-specific BMI cutoff points
were derived through the use of key cardiometabolic
RFs as outcomes. It simultaneously incorporates the
varying markers used to measure a RF, is less dependent
on the population distribution of the variables, and can
be used to characterize continuous RFs (7). We con-
cluded that the WC cutoff points should be 93.5 cm for
N Ta n dH Tm e na n d9 1 . 5c ma n d9 2 . 5c mf o rN Ta n d
HT women respectively. The cutoff point for men is
almost similar to the Europeans (94 cm) but much less
than the American cutoff point (102 cm). In women,
there is a big difference between our cutoff points (91.5
cm and 92.5 cm for NT and HT respectively) and that
of the Europeans (80 cm) but is close to that of the
Americans (88 cm) (3,6). Our study shows a small dif-
ference between the cutoff points for men and women
(1-2 cm) in contrast to a larger difference in the Eur-
opean and American cutoff points (14 cm in both popu-
lations) (3,6). A small gender difference in cutoff points
Figure 1 WC cutoff point by ROC curve in NT men. AUC = 0.78,
p < 0.001 CI: 0.685- 0.876.
Figure 2 WC cutoff point by ROC curve in HT men.A U C=
0.668, p < 0.001 CI: 0.618- 0.718.
Figure 3 WC cutoff point by ROC curve in NT women.A U C=
0.697, p < 0.001 CI: 0.619- 0.776.
Figure 4 WC cutoff point by ROC curve in HT women.A U C=
0.63, p < 0.001 CI: 0.587- 0.673.
Ibrahim et al. BMC Cardiovascular Disorders 2011, 11:53
http://www.biomedcentral.com/1471-2261/11/53
Page 5 of 8was also found in the Korean population (13), while the
cut off points were greater in Japanese women (90 cm),
compared to men (85 cm) (14).
Abdominal obesity is a common health problem in
Egypt, with a prevalence rate of 33.8% and 54.6% for
NT and HT men respectively, and 42.8% and 55.9%
for NT and HT women respectively, when applying
our new WC cutoff points derived from the present
study. These prevalence rates are higher than that
reported for US men (WC > 102 cm, 29.8%) but close
to that of women (WC > 88 cm, 46.3%) (15). The cut-
off point proposed by IDF and WHO to define
abdominal obesity in women is lower than those
found in our study (3,6). Therefore, prevalence rates
of abdominal obesity in Egyptian women based upon
the new cutoff points are different from those based
on the IDF guidelines. The Egyptian prevalence rates
exceeded those reported in many European and Afri-
can countries (16, 17). In European men and women,
abdominal obesity defined according to cutoff values
between 90-102 cm for men and 80-92 cm for
women, was 23 and 65% in Spain (17), 8 and 13% in
France (18), 21 and 24% in Belgium (19), and 18 and
39% in Turkey (20). In Cameroon, the prevalence of
abdominal obesity was 18% in men (WC > 94 cm) and
66% in women (WC > 80 cm) (21).
The association between increase in WC and cardio-
metabolic RFs, though reported in developed countries,
was rarely addressed in developing countries with differ-
ent genetic, lifestyle and environmental backgrounds.
The present study is the first to report specific abdom-
inal cutoff points estimated with waist girth and are
associated with increased cardiovascular risk among
Egyptians. It is also the first to provide information
about the prevalence of abdominal obesity in nationwide
sample of Egyptians representative of all socioeconomic
strata and geographic regions and including NT and HT
individuals.
We investigated the correlation between WC and car-
diometabolic RFs such as type 2 diabetes mellitus,
increased LDL-C and TG, decreased HDL-C and
increased LVMI determined echocardiographically. Our
data shows a continuous increase in RFs levels with
higher WC in a linear fashion. However, this linear
trend was not significant for all RFs and there was a
gender difference. On the other hand, prevalence of
abdominal obesity was higher in HT than NT subjects
above the age of 45 years.
The higher prevalence of obesity in urban area and in
upper socioeconomic class is possibly related to the rich
caloric diet and more sedentary lifestyle in this popula-
tion compared to rural residents and those in the lower
socioeconomic group.
Given the continuous increase in prevalence of cardio-
vascular RFs with increasing WC shown by the present
d a t a ,i tm u s tb ea c k n o w l e d g e dt h a ta l lt h ec u t o f fp o i n t s
are arbitrary; no threshold in WC can be determined
below which there is no increase in CVD risk and above
which there is a uniform increase in risk.
Figure 5 Prevalence of Abdominal Obesity(%) in Different Age
Decades in Normotensive and Hypertensive Men.
Figure 6 Prevalence of Abdominal Obesity(%) in Different Age
Decades in Normotensive and Hypertensive Women.
Table 4 Prevalence of abdominal obesity by the new
cutoff points in different socioeconomic classes and
urban/rural areas among NT and HT men and women
Low SES
N (%)
Mid SES
N (%)
High
SES
N (%)
Urban
N (%)
Rural
N (%)
NT and HT
males
121
(32.7)
271
(55.1)
71 (69.6) 393
(56.3)
70
(26.3)
NT females 62 (31.2) 103
(52.3)
20 (55.6) 153
(50.8)
32
(24.4)
HT females 163
(41.5)
270
(68.2)
52 (65.8) 419
(66.4)
66
(27.8)
NT and HT males were grouped together because they had similar WC cutoff
point for abdominal obesity.
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and could identify persons who are at a greater cardio-
metabolic risk more than BMI (22, 23). Abdominal obe-
sity was reported to be associated with greater risk of
hypertension, diabetes and coronary artery disease (24-
27). The additional health risk explained by WC likely
reflects its ability to act as a surrogate for abdominal-
and in particular- visceral fat (28).
CVD is now the main cause of mortality among Egyp-
tians, being responsible for 47% of deaths according to
the Egyptian Central Agency for Mobilization and Sta-
tistics (29). The age standardized mortality rates for
CVD in Egypt were 560 per 100.000 populations in the
year 2008 exceeding many European (France 118, Ger-
many 211, Finland 401) and African countries (Ethiopia
435, Djibouti 533) according to WHO statistics 2008
(30). Ischemic heart disease being responsible for 21% of
all deaths in Egypt in the year 2002 (WHO statistics:
Death and DALY estimates by cause, 2002) (31). The
high prevalence rates of abdominal obesity and asso-
ciated cardiometabolic RFs among Egyptians is possibly
an important factor behind the high CV risk.
Our study has a number of limitations. The cross-sec-
tional nature of the study precludes definite causal infer-
ence about the association between the WC and RFs.
The data are limited to the Egyptian population and
may not represent the WC cutoff values required for
definition of abdominal obesity in other Middle Eastern
countries. Additional work in other populations is
required to determine the generalizability of these
thresholds. We used ROC analysis to define the optimal
cutoff values of the WC associated with RFs, however,
the discriminatory power was relatively weak. The sensi-
tivity and specificity using these cutoff values were
rather modest. Setting a cutoff level to obtain a high
sensitivity of at least 80% will considerably decrease spe-
cificity. The cutoffs recommended here were obtained at
WC values that best balanced sensitivity and specificity.
The areas under the curves (AUC) ranged between 0.63
and 0.78, which reflects fair to good classification
boundaries, the P value was highly significant (P <
0.001) in all groups and with narrow confidence
intervals.
The present study did not have direct measures of
body fatness or fat distribution. Because WC is consid-
ered a surrogate for body fatness and fat distribution,
future research is needed into racial-ethnic differences
in the relation between WC and actual body fatness and
body fat distribution. Such studies would assist in deter-
mining whether some populations preferentially deposit
abdominal fat and would help to develop WC cutoff
points.
The study by the Emerging Risk Factors Collaboration
(32) concluded that BMI, WC and waist-to-hip ratio,
whether assessed singly or in combination, do not
importantly improve CVD risk prediction in people in
developed countries when additional information is
available for systolic blood pressure, history of diabetes
and lipids. The study does not underestimate the value
of our work, since the definition of WC cutoff points
and diagnosis of abdominal obesity is required, not only
for risk stratification and prediction of future CV events,
but also as essential component of the metabolic syn-
drome (3). Being an increasingly important condition
and one established CVD risk factor, its prevalence is
not known in many countries. The identification of
appropriate ethnic-specific targets, whether BMI or WC,
will have a major impact on the prevalence of metabolic
syndrome and cardiometabolic disease risk at a popula-
tion level. Furthermore, one should not ignore the need
for healthy lifestyle to control abdominal obesity in the
community. The target WC associated with increased
CV risk and normal levels should be defined for each
population. Guidelines should be population-specific
regarding the optimal WC which is recommended in
public education programs. There is the practical con-
sideration of what threshold justifies the expenditure of
national medical resources for clinical intervention (e.g.
nutritional and physical activity counseling) in contrast
to public health interventions (6).
Conclusion
This is the first report of specific abdominal obesity cut-
off points in a Middle Eastern country. There is a high
prevalence rate of abdominal obesity among Egyptians
which is associated with increased prevalence of cardio-
metabolic RFs.
Long-term prospective studies are required to reach
more reliable WC cutoff points for different ethnic
groups. Cross-sectional and longitudinal data relating
WC to the risk of both CVD and type-2 diabetes are
needed. Epidemiologic studies are also needed to under-
stand the causes of CVD internationally and determine
its magnitude in low-income countries. The data in the
Egyptian study might be useful in this regard. Also,
there is an urgent need in Egypt to describe a public
health strategy to adequately enhance behavioral trans-
formation necessary for total and abdominal obesity
reduction.
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